Christopher P Montgomery1, Michael Z David, Robert S Daum. 1. aSections of Critical Care bInfectious Diseases, Department of Pediatrics cSection of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Abstract
PURPOSE OF REVIEW: Staphylococcus aureus is the most common cause of skin and soft tissue infections (SSTI) in the United States and elsewhere. Recurrent infections occur frequently in patients with S. aureus SSTI, underscoring the need to better understand the nature of protective immunity against these infections. Here, we review recent findings concerning the host factors that predispose to S. aureus SSTI. RECENT FINDINGS: Recurrent infections occur in nearly half of all patients with S. aureus SSTI. Epidemiologic and environmental factors, such as exposure to healthcare, age, and household contacts with S. aureus SSTI, and contaminated household fomites are associated with recurrence. The majority of the population has evidence of antistaphylococcal antibodies, but whether these are protective remains enigmatic. In contrast, recent clinical and experimental findings clearly highlight the critical roles of innate and T cell-mediated immunity in defense against these infections. S. aureus interferes with innate and adaptive immunity by a number of recently elucidated mechanisms. SUMMARY: Recurrent S. aureus SSTIs are common, suggesting incomplete or absent protective immunity among these patients. Our understanding of protective immunity against recurrent infections is incomplete, and further basic and translational investigation is urgently needed to design strategies to prevent and treat these infections.
PURPOSE OF REVIEW: Staphylococcus aureus is the most common cause of skin and soft tissue infections (SSTI) in the United States and elsewhere. Recurrent infections occur frequently in patients with S. aureus SSTI, underscoring the need to better understand the nature of protective immunity against these infections. Here, we review recent findings concerning the host factors that predispose to S. aureus SSTI. RECENT FINDINGS: Recurrent infections occur in nearly half of all patients with S. aureus SSTI. Epidemiologic and environmental factors, such as exposure to healthcare, age, and household contacts with S. aureus SSTI, and contaminated household fomites are associated with recurrence. The majority of the population has evidence of antistaphylococcal antibodies, but whether these are protective remains enigmatic. In contrast, recent clinical and experimental findings clearly highlight the critical roles of innate and T cell-mediated immunity in defense against these infections. S. aureus interferes with innate and adaptive immunity by a number of recently elucidated mechanisms. SUMMARY: Recurrent S. aureus SSTIs are common, suggesting incomplete or absent protective immunity among these patients. Our understanding of protective immunity against recurrent infections is incomplete, and further basic and translational investigation is urgently needed to design strategies to prevent and treat these infections.
Authors: András N Spaan; Thomas Henry; Willemien J M van Rooijen; Magali Perret; Cédric Badiou; Piet C Aerts; Johan Kemmink; Carla J C de Haas; Kok P M van Kessel; François Vandenesch; Gérard Lina; Jos A G van Strijp Journal: Cell Host Microbe Date: 2013-05-15 Impact factor: 21.023
Authors: Loren G Miller; Samantha J Eells; Michael Z David; Nancy Ortiz; Alexis R Taylor; Neha Kumar; Denise Cruz; Susan Boyle-Vavra; Robert S Daum Journal: Clin Infect Dis Date: 2014-11-26 Impact factor: 9.079
Authors: Ranjani Prabhakara; Oded Foreman; Roberto De Pascalis; Gloria M Lee; Roger D Plaut; Stanley Y Kim; Scott Stibitz; Karen L Elkins; Tod J Merkel Journal: Infect Immun Date: 2013-02-04 Impact factor: 3.441
Authors: Stephanie A Fritz; Kristin M Tiemann; Patrick G Hogan; Emma K Epplin; Marcela Rodriguez; Duha N Al-Zubeidi; Juliane Bubeck Wardenburg; David A Hunstad Journal: Clin Infect Dis Date: 2013-02-27 Impact factor: 9.079
Authors: Claire E Bocchini; Edward O Mason; Kristina G Hulten; Wendy A Hammerman; Sheldon L Kaplan Journal: Pediatr Infect Dis J Date: 2013-11 Impact factor: 2.129
Authors: Arby Abtin; Rohit Jain; Andrew J Mitchell; Ben Roediger; Anthony J Brzoska; Shweta Tikoo; Qiang Cheng; Lai Guan Ng; Lois L Cavanagh; Ulrich H von Andrian; Michael J Hickey; Neville Firth; Wolfgang Weninger Journal: Nat Immunol Date: 2013-11-24 Impact factor: 25.606
Authors: Francis Alonzo; Lina Kozhaya; Stephen A Rawlings; Tamara Reyes-Robles; Ashley L DuMont; David G Myszka; Nathaniel R Landau; Derya Unutmaz; Victor J Torres Journal: Nature Date: 2012-12-12 Impact factor: 49.962
Authors: Carly A Dillen; Bret L Pinsker; Alina I Marusina; Alexander A Merleev; Orly N Farber; Haiyun Liu; Nathan K Archer; Da B Lee; Yu Wang; Roger V Ortines; Steven K Lee; Mark C Marchitto; Shuting S Cai; Alyssa G Ashbaugh; Larissa S May; Steven M Holland; Alexandra F Freeman; Loren G Miller; Michael R Yeaman; Scott I Simon; Joshua D Milner; Emanual Maverakis; Lloyd S Miller Journal: J Clin Invest Date: 2018-02-05 Impact factor: 14.808
Authors: Taj Azarian; Robert S Daum; Lindsay A Petty; Jenny L Steinbeck; Zachary Yin; David Nolan; Susan Boyle-Vavra; W P Hanage; Marco Salemi; Michael Z David Journal: J Infect Dis Date: 2016-06-10 Impact factor: 5.226
Authors: Chih-Ming Tsai; Nicole Soper; Monique Bennett; Jonathan K Fallon; Ashlin R Michell; Galit Alter; George Y Liu; Isaac Thomsen Journal: J Infect Dis Date: 2021-04-08 Impact factor: 5.226